QNRX READ THE FULL QNRX RESEARCH REPORT FDA clears initiation of 2nd NS pivotal whole body clinical study for QRX003, CL-QRX003-002 Quoin Pharmaceuticals (NASDAQ:QNRX) reported 2Q25 results today and ...

The agency’s new program is designed to increase regulatory predictability and streamline review of domestic manufacturing ...

In the most severe erosive esophagitis patients (LA grade C or D), tegoprazan 100mg was found to be statistically superior to lansoprazole for maintenance of healing at 24 weeks. Noninferiority vs ...

The Food and Drug Administration Aug. 7 announced a new program to help improve the domestic pharmaceutical supply chain by ...

Regulatory Reviews of Aficamten for Obstructive HCM Progressing in U.S., E.U. and China; Late-Cycle Meeting with U.S. FDA ...

The initiative is a response to a Trump administration order to speed the construction of the type of new drug factories many ...

The Food and Drug Administration is launching a new program to ramp up the United States’ domestic pharmaceutical supply chain, the agency announced Thursday. The program, called FDA ...

A new program to boost U.S. drug manufacturing with streamlined processes, regulatory support. Read more here.

In line with the Trump administration’s goal to curb the United States’ reliance on overseas drug manufacturing, the FDA has ...

FDA accepts a new formulation of piflufolastat F 18, enhancing prostate cancer imaging access and efficiency, with a target ...

The U.S. Food and Drug Administration announced Thursday it is launching "FDA PreCheck" in order to help construct drug ...

As the federal government pushes for lower drug prices and more domestic production, the FDA launched a “PreCheck” program Aug. 7 to expedite approval of new U.S. drug manufacturing facilities.  FDA ...